General Information of DTT (ID: TTBN5I7)

DTT Name B-cell-specific glycoprotein B29 (CD79B) DTT Info
Gene Name CD79B

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Polatuzumab vedotin DMF6Y0L Diffuse large B-cell lymphoma 2A81 Approved [1]
------------------------------------------------------------------------------------
4 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
DCDS-4501A DMQRCX5 Diffuse large B-cell lymphoma 2A81 Phase 2 [2]
Polivy DMFCIKN Mantle cell lymphoma 2A85.5 Phase 2 [3]
RG7596 DMVXGU0 Haematological malignancy 2B33.Y Phase 2 [4]
MGD010 DMA368V Autoimmune disease 4A40-4A45 Phase 1 [5]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
CD79-targeted immunotoxins DMWP63C Non-hodgkin lymphoma 2B33.5 Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 Marine-Sourced Anti-Cancer and Cancer Pain Control Agents in Clinical and Late Preclinical Development. Mar Drugs. 2014 January; 12(1): 255-278.
3 Polatuzumab Vedotin: First Global Approval. Drugs. 2019 Sep;79(13):1467-1475.
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2852).
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)